Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Meeldijk

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Neuro-Oncology Advances|May 16, 2025
Chimeric antigen receptor-macrophages: Emerging next-generation cell therapy for brain cancerMyrthe J A Koppers, Matthijs Monnikhof, Jan Meeldijk, et al.
The Biochemical Journal|May 10, 2011
Cleavage of Notch1 by granzyme B disables its transcriptional activityGeert van Tetering, Niels Bovenschen, Jan Meeldijk, et al.
The Journal of Biological Chemistry|February 9, 2002
Wnt signaling controls the phosphorylation status of beta-cateninMascha van Noort, Jan Meeldijk, Ruurd van der Zee, et al.
Neuro-Oncology|October 11, 2022
Cellular immunotherapy for medulloblastomaMichael Y Schakelaar, Matthijs Monnikhof, Sandra Crnko, et al.
Oncotarget|March 19, 2016
Reduced serpinB9-mediated caspase-1 inhibition can contribute to autoinflammatory diseaseRobert van der Burgh, Jan Meeldijk, Lieneke Jongeneel, et al.
Cell Death Discovery|December 29, 2016
Granzymes A and K differentially potentiate LPS-induced cytokine responseAnnette C Wensink, Helena M Kok, Jan Meeldijk, et al.
Molecular Endocrinology (Baltimore, Md.)|August 9, 2003
TCF and Groucho-related genes influence pituitary growth and developmentMichelle L Brinkmeier, Mary Anne Potok, Kelly B Cha, et al.
Cellular Oncology (Dordrecht, Netherlands)|August 16, 2014
Validation of DNA promoter hypermethylation biomarkers in breast cancer--a short reportJolien S de Groot, Xiaojuan Pan, Jan Meeldijk, et al.
Frontiers in Immunology|October 25, 2021
Collagen Fragments Produced in Cancer Mediate T Cell Suppression Through Leukocyte-Associated Immunoglobulin-Like Receptor 1Saskia V Vijver, Akashdip Singh, Eline T A M Mommers-Elshof, et al.
Journal for Immunotherapy of Cancer|March 17, 2023
Serpin B9 controls tumor cell killing by CAR T cellsThomas Kimman, Anne Slomp, Anne Martens, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Neuro-Oncology Advances|May 16, 2025
Chimeric antigen receptor-macrophages: Emerging next-generation cell therapy for brain cancerMyrthe J A Koppers, Matthijs Monnikhof, Jan Meeldijk, et al.
The Biochemical Journal|May 10, 2011
Cleavage of Notch1 by granzyme B disables its transcriptional activityGeert van Tetering, Niels Bovenschen, Jan Meeldijk, et al.
The Journal of Biological Chemistry|February 9, 2002
Wnt signaling controls the phosphorylation status of beta-cateninMascha van Noort, Jan Meeldijk, Ruurd van der Zee, et al.
Neuro-Oncology|October 11, 2022
Cellular immunotherapy for medulloblastomaMichael Y Schakelaar, Matthijs Monnikhof, Sandra Crnko, et al.
Oncotarget|March 19, 2016
Reduced serpinB9-mediated caspase-1 inhibition can contribute to autoinflammatory diseaseRobert van der Burgh, Jan Meeldijk, Lieneke Jongeneel, et al.
Cell Death Discovery|December 29, 2016
Granzymes A and K differentially potentiate LPS-induced cytokine responseAnnette C Wensink, Helena M Kok, Jan Meeldijk, et al.
Molecular Endocrinology (Baltimore, Md.)|August 9, 2003
TCF and Groucho-related genes influence pituitary growth and developmentMichelle L Brinkmeier, Mary Anne Potok, Kelly B Cha, et al.
Cellular Oncology (Dordrecht, Netherlands)|August 16, 2014
Validation of DNA promoter hypermethylation biomarkers in breast cancer--a short reportJolien S de Groot, Xiaojuan Pan, Jan Meeldijk, et al.
Frontiers in Immunology|October 25, 2021
Collagen Fragments Produced in Cancer Mediate T Cell Suppression Through Leukocyte-Associated Immunoglobulin-Like Receptor 1Saskia V Vijver, Akashdip Singh, Eline T A M Mommers-Elshof, et al.
Journal for Immunotherapy of Cancer|March 17, 2023
Serpin B9 controls tumor cell killing by CAR T cellsThomas Kimman, Anne Slomp, Anne Martens, et al.
Pageof 3